Media Advisory

Australia’s top-selling veterinary product, Sasha’s Blend™ is poised for a market breakthrough in the U.S. - the first country in the global marketplace where the product will be available for general retail (non-veterinary) sale.

Erik Jaason joins Interpath Pty Ltd, as exclusive agent for USA Health and Lifestyle markets.

For immediate release - November 30, 2006

Interpath Pty Ltd., is pleased to announce the appointment of Erik Jaason  as the exclusive American Agent for its revolutionary Animal Health products Sasha's Blend™, Sasha's EQ™, and Human Health product JointXL™.  Mr. Jaason will be responsible for spearheading product expansion to the U.S. marketplace and for forging value-added partnerships.

Prior to joining the Interpath team, Mr.Jaason spent 10 years in senior professional service and sales roles in the medical/healthcare and legal/web technology sectors. Mr. Jaason also serves on the Board of Directors for the Chicago Estonian House, Inc.

Mr. Jaason holds a Bachelor of Business Management Degree from Ryerson Polytechnic University in Toronto, Canada.


About Interpath Pty Ltd

Interpath Pty Ltd., is an industry leader specializing in the scientific research and development for the treatment of tissue and cellular inflammation. The company is globally positioned as the forerunner in the revolution of non-pharmaceutical treatment of arthritis and prevention of joint disease in humans and animals. Interpath Pty Ltd., was established with a view to developing global markets for health-based products.

Interpath Pty Ltd is a privately-held multi-national company headquartered in Ballarat Australia, with offices in the U.S., Canada, The Netherlands, and South Africa and distributors in  Ireland, New Zealand, China, Singapore, Japan, Hong Kong and Portugal. It also has contracted research facilities in Australia, Canada and New Zealand.

For more information visit Interpath’s website at www.interpath.net.au


About Sasha’s Blend

Sasha’s Blend™ is a carefully-developed all-natural food additive harvested from the sea. It is a concentrated powdered mix of abalone, shark cartilage, New Zealand Green Lipped Mussel and other natural ingredients (no fillers). Its efficacious substances include anti-inflammatory peptides, long-chain polyunsaturated fatty acids and glycogen. Because of the stomach-soothing properties of the New Zealand Green Lipped Mussel, Sasha’s Blend can be used beneficially with prescribed non-steroidal anti-inflammatory drugs (NSAIDS).  Its efficacy is backed up by clinical studies.

Australia’s top-selling veterinary product, Sasha’s Blend™ is poised for a market breakthrough in the U.S. - the first country in the global marketplace where the product will be available for general retail (non-veterinary) sale.

But the real testament to the soundness of Sasha’s Blend ™ science comes from dog-owners worldwide, and from humans who have tried the “People Blend,”JointXL, soon to be available in U.S.A.  For more information  visit www.sashasblend.com - www.jointxl.com

“Interpath puts its money into science”

close this window